로딩 중…
지수 로딩 중…
Beam Therapeutics Inc.
BEAM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$34.14+5.11%
2026-06-18
Price Chart
Beam Therapeutics Inc.+100.94%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.51B |
| Revenue | $164M |
| Net Income | $-65M |
| Total Assets | $1.48B |
| Net Assets | $1.16B |
| Value | |
| P/B | 3.02x |
| P/S | 21.41x |
| FCF Yield | -10.93% |
| Profitability | |
| ROE | -5.59% |
| ROA | -4.39% |
| Op. Margin | -226.58% |
| Revenue Growth | 324.87% |
| Financial Health | |
| Debt Ratio | 27.17% |
| Total Debt | $251M |
| FCF | $-384M |
| Cash | $288M |
| Current Ratio | 16.99x |
| Performance | |
| 1Y Return | 100.94% |
| 1M Return | 29.66% |
| From 52W High | -6.31% |
| 1Y MDD | -38.15% |
| Trading | |
| Volume | 2,736,915 shares |
| Trading Value | $92M |
| Per Share | |
| EPS | $-0.78 |
| BPS | $12.04 |